Journal Mobile Options
Table of Contents
Vol. 18, No. 4, 2005
Issue release date: July–August 2005
Skin Pharmacol Appl Skin Physiol 2005;18:170–174

Sunscreen Penetration of Human Skin and Related Keratinocyte Toxicity after Topical Application

Hayden C.G.J. · Cross S.E. · Anderson C. · Saunders N.A. · Roberts M.S.
aTherapeutics Research Unit, University of Queensland, Southern Clinical School, University of Queensland, Princess Alexandra Hospital, Brisbane; bDepartment of Dermatology, Liverpool Health Service, Liverpool, and cEpithelial Pathobiology Group, Centre for Immunology and Cancer Research, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Sunscreen skin penetration and safety assessment should be considered together in order to ensure that in vitro cytotoxicity studies examine relevant doses of these organic chemical UV filters to which viable epidermal cells are realistically exposed. In this study, we sought to determine whether sufficient topically applied sunscreens penetrated into human viable epidermis to put the local keratinocyte cell populations at risk of toxicity. The penetration and retention of five commonly used sunscreen agents (avobenzone, octinoxate, octocrylene, oxybenzone and padimate O) in human skin was evaluated after application in mineral oil to isolated human epidermal membranes. Sunscreen concentration–human keratinocyte culture response curves were then defined using changes in cell morphology and proliferation (DNA synthesis using radiolabelled thymidine uptake studies) as evidence of sunscreens causing toxicity. Following 24 h of human epidermal exposure to sunscreens, detectable amounts of all sunscreens were present in the stratum corneum and viable epidermis, with epidermal penetration most evident with oxybenzone. The concentrations of each sunscreen found in human viable epidermis after topical application, adjusting for skin partitioning and binding effects, were at least 5-fold lower, based on levels detected in viable epidermal cells, than those appearing to cause toxicity in cultured human keratinocytes. It is concluded that the human viable epidermal levels of sunscreens are too low to cause any significant toxicity to the underlying human keratinocytes.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Nohynek GJ, Schaefer H: Benefit and risk of organic ultraviolet filters. Regul Toxicol Pharmacol 2001;33:285–299.
  2. CIR: Final report on the safety assessment of benzophenones -1, -3, -4, -5, -9 and -11, Cosmetic Ingredient Review. J Am Coll Toxicol 1983;2:35–77.
  3. Gustavsson Gonzalez H, Farbrot A, Larko O: Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol 2002;27:691–694.
  4. Jiang R, Roberts MS, Collins D, Benson HAE: Absorption of sunscreens across human skin: An evaluation of commercial products for children and adults. Br J Clin Pharmacol 1999;48:635–637.
  5. Hayden C, Roberts MS, Benson HAE: Systemic absorption of sunscreen after topical application. Lancet 1997;350:863–864.
  6. Treffel P, Gabard B: Skin penetration and sun protection factor of ultra-violet filters from two vehicles. Pharm Res 1996;13:770–774.
  7. Schlumpf M, Cotton B, Conscience M, Haller V, Steinman B, Lichtensteiger W: In vitro and in vivo estrogenicity of UV screens. Environ Health Perspec 2001;109:239–244.
  8. Xu C, Green A, Parisi A, Parsons P: Photosensitization of the sunscreen octyl p-dimethylaminobenzoate by UVA in human melanocytes but not in keratinocytes. Photochem Photobiol 2001;73:600–604.
  9. Xu C, Parsons P: Cell cycle delay, mitochondrial stress and uptake of hydrophobic cations induced by sunscreens in cultured human cells. Photochem Photobiol 1999;69:611–616.
  10. Maeran L, Law S, Storrs FL: Contact urticaria, allergic contact dermatitis and photoallergic contact dermatitis from oxybenzone. Am J Contact Dermatitis 2003;14:33–34.

    External Resources

  11. Zhang XM, Nakagawa M, Kawai K, Kawai K: Erythema-multiform-like eruption following photoallergic contact dermatitis from oxygenzone. Contact Dermatitis 1998;38:43–44.
  12. Schauder S, Ippen H: Contact and photocontact sensitivity to sunscreens. Review of a 15-year experience and of the literature. Contact Dermatitis 1997;37:221–232.
  13. Mancel E, Drouet M, Sabbah A, Avenel-Audran M: Allergy to sunscreens. Allergy Immunol 1999;31:195–199.
  14. Hayden C, Roberts M, Benson H: Sunscreens: Are Australians getting the good oil? Aust NZ J Med 1998;28:639–646.
  15. Kligman A, Christophers E: Preparation of sheets of isolated human stratum corneum. Arch Dermatol 1963;88:70–73.
  16. Jiang R, Hayden C, Prankerd R, Roberts MS, Benson HAE: High-performance liquid chromatographic assay for common sunscreening agents in cosmetic products, bovine serum albumin solution and human plasma. J Chromatogr B Biomed Appl 1996;682:137–145.
  17. Dahler A, Jones S, Dicker A, Saunders N: Keratinocyte growth arrest is associated with activation of transcriptional repressor element in the human cdk1 promotor. J Cell Physiol 1998;177:474–482.
  18. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985;150:76–85.
  19. Christopoulos A: Assessing the distribution of parameters in models of ligand-receptor interaction: To log or not to log. Trends Pharmacol Sci 1998;19:351–357.
  20. Felton LA, Wiley CJ, Godwin DA: Influence of hydroxypropyl-β-cyclodextrin on the transdermal permeation and skin accumulation of oxybenzone. Drug Dev Ind Pharm 2002;28:1117–1124.
  21. Seibert H, Morchel S, Gulden M: Factors influencing nominal effective concentrations of chemical compounds in vitro: Medium protein concentration. Toxicol In Vitro 2002;16:289–297.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50